Company: NCEL
Filing Date: 2025-03-03
Form Type: F-4/A
Source: 0001213900-25-018981
Chunk: 483

Company: NewcelX Ltd.
Filing Date: 2025-03-03
Form: F-4/A
Chunk 483
---
konto ) in the name of Parent:

| Account Holder:     |     | NLS Pharmaceutics AG                             |
| USD Account Number: |     | 206 -196654.61Q                                  |
| IBAN:               |     | CH72 0020 6206 1966 5461 Q                       |
| Bank Name:          |     | UBS SWITZERLAND AG                               |
| Bank Address:       |     | Bahnhofstrasse 45                                |
|                     |     | CH-8098 Zürich                                   |
| BIC/SWIFT:          |     | UBSWCHZH80A                                      |
| Reference:          |     | Share Capital Increase of NLS Pharmaceutics Ltd. |

Annex A-39 (iii) The Parties shall cause the Swiss bank to immediately issue a written confirmation evidencing that the nominal value for each Merger Share that was settled in cash in accordance with Section 5.6.3(b)(ii) above, has been fully credited to the following special purpose blocked capital account of Parent ( Kapitaleinzahlungssperrkonto ); (iv) If and to the extent that the Merger Shares will not be settled in cash in accordance with Section 5.6.3(b)(ii) above, the Company shall procure that the Exchange Agent will settle the remaining amount of the aggregated nominal value of the Merger Shares by way of contribution in kind for account of Company, by transferring ownership of the non-cash assets to Parent, all in full compliance with art. 634 of the Swiss Code of Obligations (CO) and executing an agreement on contribution-in-kind with Parent, in form and substance satisfactory to Parent; and (v) Parent shall procure that an auditor, duly accredited to perform such kind of auditing services in Switzerland, will deliver the auditors’ report ( Prüfungsbestätigung ) confirming the completeness and accuracy of the contributions of the Parent Board’s capital increase report. (c) If and immediately after (I) the completion of all actions under Section 5.6.3(b) and (II) all conditions precedent to consummate the Merger in accordance with Article VI have been satisfied, but in any event no later than six months after the date of the EGM, Parent shall procure that Parent Board will take the resolutions on the ascertainment and the execution of the Capital Increase ( Feststellungsbeschluss ) in the presence of a public notary (